PURPOSE: We wished to determine incidence, clinical features, and prognosis of benign rolandic seizures (BRS) and benign rolandic epilepsy (BRE) in a total population. METHODS: Cases were ascertained through review of all EEG records, and diagnosis was verified by review of medical records. Follow-up information regarding seizures and treatment was obtained from parents and treating physicians. RESULTS: In the Icelandic population aged 3-15 years, the incidence of BRS is 6.2 and BRE 4.7 in 100,000. Five years after onset 95% were seizure-free. At last follow-up, all were seizure free and had not been treated with antiepileptic drugs (AEDs) for at least 1 year. CONCLUSIONS: Our study demonstrates that BRS is a common entity in children. The prognosis is excellent and treatment is not necessary in all cases. It is important to identify BRE/BRS correctly and distinguish it from other types of epilepsy.
PURPOSE: We wished to determine incidence, clinical features, and prognosis of benign rolandic seizures (BRS) and benign rolandic epilepsy (BRE) in a total population. METHODS: Cases were ascertained through review of all EEG records, and diagnosis was verified by review of medical records. Follow-up information regarding seizures and treatment was obtained from parents and treating physicians. RESULTS: In the Icelandic population aged 3-15 years, the incidence of BRS is 6.2 and BRE 4.7 in 100,000. Five years after onset 95% were seizure-free. At last follow-up, all were seizure free and had not been treated with antiepileptic drugs (AEDs) for at least 1 year. CONCLUSIONS: Our study demonstrates that BRS is a common entity in children. The prognosis is excellent and treatment is not necessary in all cases. It is important to identify BRE/BRS correctly and distinguish it from other types of epilepsy.
Authors: Emily L Thorn; Lauren M Ostrowski; Dhinakaran M Chinappen; Jin Jing; M Brandon Westover; Steven M Stufflebeam; Mark A Kramer; Catherine J Chu Journal: Epilepsia Date: 2020-09-18 Impact factor: 5.864
Authors: Mark A Kramer; Sally M Stoyell; Dhinakaran Chinappen; Lauren M Ostrowski; Elizabeth R Spencer; Amy K Morgan; Britt Carlson Emerton; Jin Jing; M Brandon Westover; Uri T Eden; Robert Stickgold; Dara S Manoach; Catherine J Chu Journal: J Neurosci Date: 2021-01-19 Impact factor: 6.167
Authors: Naim Panjwani; Michael D Wilson; Laura Addis; Jennifer Crosbie; Elaine Wirrell; Stéphane Auvin; Roberto H Caraballo; Maria Kinali; David McCormick; Caroline Oren; Jacqueline Taylor; John Trounce; Tara Clarke; Cigdem I Akman; Steven L Kugler; David E Mandelbaum; Patricia McGoldrick; Steven M Wolf; Paul Arnold; Russell Schachar; Deb K Pal; Lisa J Strug Journal: Ann Clin Transl Neurol Date: 2016-06-02 Impact factor: 4.511
Authors: Laura Addis; William Sproviero; Sanjeev V Thomas; Roberto H Caraballo; Stephen J Newhouse; Kumudini Gomez; Elaine Hughes; Maria Kinali; David McCormick; Siobhan Hannan; Silvia Cossu; Jacqueline Taylor; Cigdem I Akman; Steven M Wolf; David E Mandelbaum; Rajesh Gupta; Rick A van der Spek; Dario Pruna; Deb K Pal Journal: J Med Genet Date: 2018-05-22 Impact factor: 6.318